SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934

                        Date of Report: August 16, 2005
                        (Date of earliest event reported)

                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                       0-18105               11-2871434
(State or other                  (Commission           (IRS Employer
 jurisdiction of                  File Number)         Identification
 incorporation)                                           Number)


180 Linden Avenue, Westbury, New York                    11590
  (Address of principal executive offices)            (Zip Code)



Registrant's telephone number including area code    (516) 997-4600


                                 Not applicable
         (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act 
     (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act 
     (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the 
     Exchange Act

[  ] Pre-commencement communications pursuant to Rule 13e-4c under the 
     Exchange Act (17 CFR 240.13e-4c)



                    INFORMATION TO BE INCLUDED IN THE REPORT

     The  information in this Form 8-K Current  Report and the exhibit  attached
hereto is furnished  and shall not be deemed  "filed" for purposes of Section 18
of the  Securities  Exchange Act of 1934, as amended (the  "Exchange  Act"),  or
otherwise  subject to the  liabilities  of that Section,  nor shall it be deemed
incorporated  by reference in any filing of the Registrant  under the Securities
Act of 1933, as amended,  or the Exchange Act,  except as shall be expressly set
forth by specific reference in such filing.

Item 2.02   Results of Operations and Financial Condition

     On August 16, 2005,  Vasomedical,  Inc.  issued an earnings  press  release
announcing  its financial  results for the fourth  quarter and fiscal year ended
May 31, 2005. A copy of the earnings  press release is attached as Exhibit 99 to
this Current Report on Form 8-K.

Item 9.01   Financial Statements and Exhibits

     (c) Exhibits

     99   Earnings Release,  dated August 16, 2005,  announcing the Registrant's
          financial results for the fourth quarter and fiscal year ended May 31,
          2005.


                                   
                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                      VASOMEDICAL, INC.


                                      By: /s/ Thomas Glover
                                          Thomas Glover
                                          President and Chief Executive Officer


Dated:   August 19, 2005